MRVI·56600D107·US·equity·Healthcare - Biotechnology-13D/G
MRVI (MARAVAI LIFESCIENCES HLDGS A) is held by 86 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($26.4M), MACKENZIE FINANCIAL CORP ($17.8M), RENAISSANCE TECHNOLOGIES LLC ($12.1M). Net institutional sentiment: Mixed.
See how MRVI's score breaks down across 4 SEC sources
Showing 1-20 of 94
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer